AP
CRL icon

Advisor Partners’s Charles River Laboratories CRL Stock Holding History

Advisor Partners’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$383K Buy
1,790
+252
+16% +$61.6K 0.03% 563
2022
Q1 		$437K Buy
1,538
+7
+0.5% +$2.16K 0.03% 557
2021
Q4 		$577K Sell
1,531
-16
-1% -$6.22K 0.03% 475
2021
Q3 		$638K Sell
1,547
-84
-5% -$34.9K 0.04% 413
2021
Q2 		$603K Buy
1,631
+53
+3% +$17.7K 0.04% 444
2021
Q1 		$457K Buy
1,578
+21
+1% +$5.84K 0.03% 499
2020
Q4 		$389K Buy
1,557
+44
+3% +$10.5K 0.03% 517
2020
Q3 		$343K Sell
1,513
-197
-12% -$40.9K 0.03% 490
2020
Q2 		$298K Buy
1,710
+25
+1% +$3.99K 0.03% 519
2020
Q1 		$212K Sell
1,685
-114
-6% -$17.1K 0.03% 532
2019
Q4 		$286K Sell
1,799
-76
-4% -$10.5K 0.03% 506
2019
Q3 		$248K Buy
1,875
+20
+1% +$2.68K 0.03% 541
2019
Q2 		$263K Sell
1,855
-102
-5% -$13.8K 0.03% 501
2019
Q1 		$284K Sell
1,957
-166
-8% -$21.8K 0.04% 468
2018
Q4 		$240K Buy
2,123
+72
+4% +$9.02K 0.04% 474
2018
Q3 		$276K Sell
2,051
-6
-0.3% -$741 0.04% 485
2018
Q2 		$231K Buy
2,057
+156
+8% +$16.9K 0.04% 494
2018
Q1 		$203K Sell
1,901
-254
-12% -$27.4K 0.04% 527
2017
Q4 		$233K Buy
2,155
+4
+0.2% +$435 0.04% 482
2017
Q3 		$232K Buy
2,151
+94
+5% +$9.66K 0.05% 421
2017
Q2 		$208K Buy
+2,057
New +$189K 0.05% 435

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisor Partners's CRL Position: Q2 2022 in Review

Advisor Partners increased its Charles River Laboratories (CRL) stake by 16% in Q2 2022, buying an estimated $61.6K and bringing the position to 1,790 shares worth $383K. The position accounts for 0.03% of the portfolio, ranked #563.

Advisor Partners first reported a position in CRL in Q2 2017 and has held it in 21 quarters since. The position peaked at $638K in Q3 2021. 628 funds tracked by Wall St. Rank hold CRL as of Q2 2022.

  • Advisor Partners held 1,790 shares of Charles River Laboratories worth $383K as of Q2 2022.
  • Advisor Partners bought 252 Charles River Laboratories shares in Q2 2022, an estimated $61.6K.
  • Charles River Laboratories made up 0.03% of Advisor Partners's portfolio in Q2 2022, its #563 holding.
  • Advisor Partners first reported a position in Charles River Laboratories in Q2 2017 and has held it in 21 quarters since.
  • Advisor Partners's Charles River Laboratories position peaked at $638K in Q3 2021.
  • 628 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2022.

Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.